Journal of Medicinal Chemistry · 2008 · 27 citations · 34 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryNeuropharmacologyPsychopharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyDrug-receptor InteractionsLigand BindingReceptor Pharmacology5-Hydroxytryptamine 1A Receptor Agonists5-Hydroxytryptamine Receptor PharmacologyChemical AffinityIndole ChemistryIndole DerivativesPharmacology Of Serotonergic AgentsSerotonin Receptor BindingSerotonin Receptor Pharmacology
Novel compounds combining a 5-HT 1A moiety (3-aminochroman scaffold) and a 5-HT transporter (indole analogues) linked through a common basic nitrogen via an alkyl chain attached at the 1- or 3-position of the indole were evaluated for dual affinity at both the 5-HT reuptake site and the 5-HT 1A receptor. Compounds of most interest were found to have a 5-carbamoyl-8-fluoro-3-amino-3,4-dihydro-2 H-1-benzopyran linked to a 3-alkylindole (straight chain), more specifically substituted with a 5-fluoro (( R)-(-)- 35c), 5-cyano ((-)- 52a), or 5,7-difluoro ((-)- 52g). Several factors contributed to 5-HT 1A affinity, serotonin rat transporter affinity, and functional antagonism in vitro. Although most of our analogues showed good to excellent affinities at both targets, specific features such as cyclobutyl substitution on the basic nitrogen and stereochemistry at the 3-position of the chroman moiety seemed necessary for antagonism at the 5-HT 1A receptor. Branched linkers seemed to impart antagonism even as racemates; however, the potency of these analogues in the functional assay was not desirable enough to further pursue these compounds.
34
P E Greenberg, L E Stiglin, Stan N. Finkelstein et al. · PharmacoResources · 1994 · 980 citations
M.D. Hall, Salah El Mestikawy, M.B. Emerit et al. · Journal of Neurochemistry · 1985 · 459 citations